Market revenue in 2020 | USD 385.4 million |
Market revenue in 2028 | USD 740.6 million |
Growth rate | 8.5% (CAGR from 2020 to 2028) |
Largest segment | Reagents |
Fastest growing segment | Equipment |
Historical data covered | 2016 - 2019 |
Base year for estimation | 2020 |
Forecast period covered | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Reagents, Equipment |
Key market players worldwide | Thermo Fisher Scientific Inc, Lonza Group Ltd, Qiagen NV, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Merck KGaA, Origin Enterprises PLC, MaxCyte Inc, PromoCell GmbH, Promega, Polyplus-transfection, Horizon Discovery |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to transfection reagents & equipment market will help companies and investors design strategic landscapes.
Reagents was the largest segment with a revenue share of 54.36% in 2020. Horizon Databook has segmented the North America transfection reagents & equipment market based on reagents, equipment covering the revenue growth of each sub-segment from 2016 to 2028.
Rapid development of compatible and efficient transfection technologies by manufacturers in North America has made significant contributions to the regional revenue in the global market. Additionally, large-scale adoption of gene therapies across North America has supplemented market penetration of transfection reagents and equipment.
North America is the largest geographical market for transfection reagents and equipment in the world, encompassing U.S. and Canada. These market participants continue to focus on innovating transfection applications, instrumentation, diversity of different cell lines, and their cellular interactions to develop different reagents & accessories for professionals in the drug development industry.
This is also aimed at producing specific and potent drugs along with advanced bioscience research. As per industry analysis performed by Pharmaceutical Outsourcing, speedy progress of gene and cell therapies via clinical development is expected to supplement the growth for late-stage clinical and commercial manufacturing in this region.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America transfection reagents & equipment market , including forecasts for subscribers. This continent databook contains high-level insights into North America transfection reagents & equipment market from 2016 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account